Uncompensated Care Negatively Hits HCA Holdings (HCA) 3Q Results
Tweet Send to a Friend
Leerink Partners maintained an Outperform rating on HCA Holdings (NYSE: HCA), and cut the price target to $79.00 (from $95.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


